Abstract
Purpose
According to modern bio-psychosocial theories of premenstrual syndrome (PMS), the aim of this study is to investigate systematically associations between selected psychosocial factors and premenstrual symptoms in different menstrual cycle phases.
Method
Several psychosocial variables were assessed, in a sample of German women with PMS (N = 90) and without premenstrual complaints (N = 48) during the follicular and luteal phase of the menstrual cycle. Presence of PMS was indicated by analysis of contemporary daily ratings of premenstrual symptom severity and impairment for one menstrual cycle.
Results
Regarding perceived chronic stress (ƞ 2 = 0.34), self-efficacy (ƞ 2 = 0.12), and two dimensions of self-silencing (0.06 ≤ ƞ 2 ≤ 0.11) analyses revealed only a significant effect of group. Regarding body dissatisfaction and somatosensory amplification, a significant effect of group (0.07 ≤ ƞ 2 ≤ 0.16) and additionally a group by menstrual cycle phase interaction (ƞ 2 = 0.06) was identified. Regarding relationship quality, a significant effect of menstrual cycle phase (ƞ 2 = 0.08) and a group by menstrual cycle phase interaction (ƞ 2 = 0.06) was demonstrated. In respect to sexual contentment, acceptance of premenstrual symptoms, and the remaining two dimensions of self-silencing statistical analyses revealed no effects at all. Linear multiple regression analysis revealed that 20 % of the variance in PMS symptom severity was explained by the psychosocial variables investigated. Body dissatisfaction (ß = 0.26, p = 0.018) and the divided self-dimension of self-silencing (ß = 0.35, p = 0.016) were significant correlates of PMS severity.
Conclusion
Results of this study are consistent with previous research and additionally show patterns of associations between specific psychosocial factors and PMS in dependence of menstrual cycle phase that have not been researched before. The role of the psychosocial variables we investigated in regard to the development and maintenance of PMS should be clarified in future research.
Similar content being viewed by others
References
Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affect Disord. 2005;85(3):275–82. doi:10.1016/j.jad.2004.10.004.
Tschudin S, Bertea PC, Zemp E. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample. Arch Women Ment Hlth. 2010;13(6):485–94. doi:10.1007/s00737-010-0165-3.
American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists: premenstrual syndrome. ACOG Pract Bull. 2000;15:3–8.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fifth edition. DSM-5. Washington, DC: APA; 2013.
Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrino. 2003;28 Suppl 3:1–23. doi:10.1016/S0306-4530(03)00098-2.
Halbreich U, Bäckström T, Erikkson E, et al. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol. 2007;23(3):123–30. doi:10.1080/09513590601167969.
Wittchen H, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32(1):119–32. doi:10.1017/S0033291701004925.
Kendler KS, Karkowski LM, Corey LA, Neale MC. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiat. 1998;155(9):1234–40. doi:10.1176/ajp.155.9.1234.
Backström T, Andersson A, Andree L, et al. Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci. 2003;1007:42–53. doi:10.1196/annals.1286.005.
Birzniece V, Backström T, Johansson IM, et al. Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res Rev. 2006;51(2):212–39. doi:10.1016/j.brainresrev.2005.11.001.
Blake F. Cognitive therapy for premenstrual syndrome. Cogn Behav Pract. 1995;2(1):167–85. doi:10.1016/S1077-7229(05)80009-4.
Jahromi BN, Pakmehr S, Hagh-Shenas H. Work stress, premenstrual syndrome and dysphoric disorder: are there any associations? Iran Red Crescent Med J. 2011;13(3):199–202.
Fontana A, Palfai T. Psychosocial factors in premenstrual dysphoria: stressors, appraisal, and coping processes. J Psychosom Res. 1994;38(6):557–67. doi:10.1016/0022-3999(94)90053-1.
Watanabe K, Shirakawa T. Characteristics of perceived stress and salivary levels of secretory immunoglobulin A and cortisol in Japanese women with premenstrual syndrome. Nurs Midwifery Stud. 2015;4(2):e24795. doi:10.17795/nmsjournal24795.
Gonda X, Fountoulakis K, Csukly G, et al. Increased attention for negative life events is associated with an elevated risk for premenstrual symptoms. Ann General Psychiatry. 2010;9 Suppl 1:S188. doi:10.1186/1744-859X-9-S1-S188.
Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiat. 2001;49(9):788–97. doi:10.1016/S0006-3223(00)01044-1.
Klatzkin RR, Morrow AL, Light KC, Pedersen CA, Girdler SS. Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women. Biol Psychol. 2006;71(1):2–11. doi:10.1016/j.biopsycho.2005.02.007.
Straneva P, Girdler SS, Light KC, Benjamin SE, Morrow L. Allopregnanolone, stress and mood in premenstrual dysphoric disorder. Psychosom Med. 1999;61(1):87. doi:10.1097/00006842-199901000-00030.
Sigmon ST, Rohan KJ, Boulard NE, Dorhofer DM, Whitcomb SR. Menstrual reactivity: the role of gender-specificity, anxiety sensitivity, and somatic concerns in self-reported menstrual distress. Sex Roles. 2000;43(3-4):143–61. doi:10.1023/A:1007036012911.
Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy an experiential approach to behavior change. New York: The Guilford Press; 1999.
Read JR, Perz J, Ussher JM. Ways of coping with premenstrual change: development and validation of a premenstrual coping measure. BMC Womens Health. 2014;14(1):1. doi:10.1186/1472-6874-14-1.
Ryser R, Feinauer L. Premenstrual syndrome and the marital relationship. Am J Fam Ther. 1992;20(2):179–90. doi:10.1080/01926189208250887.
Marvan ML, Martinez Millan ML. Marital communication and premenstrual symptoms [Comunicacion marital y sintomas premenstruales]. Acta Psiquiatr Psicol Am Lat. 1995;41(1):24–8.
Jack D. Silencing the self: the power of social imperatives in women’s depression. In: Formanek R, Gurian A, editors. Women and depression: a lifespan perspective. New York: Springer; 1987. p. 161–81.
Perz J, Ussher JM. Women’s experience of premenstrual syndrome: a case of silencing the self. J Reprod Infant Psyc. 2006;24(4):289–303. doi:10.1080/02646830600973883.
Chandraiah S, Levenson JL, Collins JB. Sexual dysfunction, social maladjustment, and psychiatric disorders in women seeking treatment in a premenstrual syndrome clinic. Int J Psychiat Med. 1991;21(2):189–204. doi:10.2190/A4JM-PGR9-35PH-4WCW.
Yang M, Gricar JA, Maruish ME, Hagan MA, Kornstein SG, Wallenstein GV. Interpreting premenstrual symptoms impact survey scores using outcomes in health-related quality of life and sexual drive impact. J Reprod Med. 2010;55(1-2):41–8.
Aschkenazi S, Botros S, Beaumont J, et al. The prevalence of premenstrual syndrome and premenstrual dysphoric disorder and its relationship to sexual functioning, pelvic pain and depressed mood. Int Urogynecol J. 2007;18 Suppl 1:S174–5.
Nowosielski K, Drosdzol A, Skrzypulec V, Plinta R. Sexual satisfaction in females with premenstrual symptoms. J Sex Med. 2010;7(11):3589–97. doi:10.1111/j.1743-6109.2010.01927.x.
Fallon P, Ackard DM. Sexual abuse and body image. In: Cash TF, Pruzinsky T, editors. Body image. A handbook of theory, research, and clinical practice. New York: Guilford Press; 2002. p. 117–24.
Altabe M, Thompson K. Menstrual cycle, body image, and eating disturbances. Int J Eat Disord. 1990;9(4):385–401. doi:10.1002/1098-108X(199007)9:4<395::AID-EAT2260090405>3.0.CO;2-E.
Muljat AM, Lustyk MKB, Miller A. Stress moderates the effects of premenstrual symptomatology on body image reports in women. Ann Behav Med. 2007;33:S157.
Reiss S, McNally RJ. Expectancy model of fear. In: Reiss S, Bootzin RR, editors. Theoretical issues in behavior therapy. San Diego: Academic; 1985. p. 107–21.
Sigmon ST, Schartel JG, Hermann BA, Cassel AG, Thorpe GL. The relationship between premenstrual distress and anxiety sensitivity: the mediating role of rumination. J Ration Emot Cogn Behav Ther. 2009;27(3):188–200.
Sigmon ST, Fink CM, Rohan KJ, Hotovy LA. Anxiety sensitivity and menstrual cycle reactivity: psychophysiological and self-report differences. J Anxiety Disord. 1996;10(5):393–410. doi:10.1016/0887-6185(96)00019-9.
Sigmon ST, Dorhofer DM, Rohan KJ, Hotovy LA, Boulard NE, Fink CM. Psychophysiological, somatic, and affective changes across the menstrual cycle in women with panic disorder. J Consult Clin Psychol. 2000;68(3):425–31. doi:10.1037//0022-006X.68.3.425.
Nillni YI, Rohan KJ, Mahon JN, Pineles SL, Zvolensky MJ. The role of anxiety sensitivity in the experience of menstrual-related symptoms reported via daily diary. Psychiat Res. 2013;210(2):564–9. doi:10.1016/j.psychres.2013.07.016.
Sigmon ST, Whitcomb-Smith SR, Rohan KJ, Kendrew JJ. The role of anxiety level, coping styles, and cycle phase in menstrual distress. J Anxiety Disord. 2004;18(2):177–91. doi:10.1016/S0887-6185(02)00243-8.
Craner J, Sigmon S, Martinson A, McGillicuddy M. Perceptions of health and somatic sensations in women reporting premenstrual syndrome and premenstrual dysphoric disorder. J Nerv Ment Dis. 2013;201(9):780–5. doi:10.1097/NMD.0b013e3182a213f1.
Ingram RE. Self-focused attention in clinical disorders: review and a conceptual model. Psychol Bull. 1990;107(2):156–76. doi:10.1037//0033-2909.107.2.156.
Craner JR, Sigmon ST, Martinson AA. Self-focused attention in response to laboratory stressors among women with premenstrual disorders. Arch Women Ment Hlth. 2015;18(4):595–606. doi:10.1007/s00737-015-0505-4.
Barsky AJ, Goodson JD, Lane RS, Cleary PD. The amplification of somatic symptoms. Psychosom Med. 1988;50(5):510–9. doi:10.1097/00006842-198809000-00007.
Barsky AJ, Wyshak G. Hypochondriasis and somatosensory amplification. Br J Psychiat. 1990;157:404–9. doi:10.1192/bjp.157.3.404.
Ditzen B, Nussbeck F, Drobnjak S, Spoerri C, Wueest D, Ehlert U. A German DSM-IV-TR-based questionnaire for the screening of premenstrual symptoms. Z Klin Psychol Psychother. 2011;40(3):149–59. doi:10.1026/1616-3443/a000095.
Hiller W, Zaudig M, Mombour W. IDCL. International Diagnostic Checklists for ICD-10 and DSM-IV [IDCL. Internationale Diagnosen Checklisten für ICD-10 und DSM-IV]. Bern: Huber; 1995.
Schulz P, Schlotz W, Becker P. Trier inventory for the assessment of chronic stress. Göttingen: Hogrefe; 2004.
Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Weinman J, Wright S, Johnston M, editors. Measures in health psychology: a user’s portfolio. Causal and control beliefs. Windsor: Nfer-Nelson; 1995. p. 35–7.
Hendrick S, Dicke A, Hendrick C. The relationship assessment scale. J Soc Pers Relat. 1988;15:137–42.
Meston C, Trapnell P. Development and validation of a five-factor sexual satisfaction and distress scale for women: the sexual satisfaction scale for women (SSS-W). J Sex Med. 2005;2(1):66–81.
Paul T, Thiel A. EDI-2: eating disorder inventory-2. Göttingen: Hogrefe; 2005.
Barsky A, Wyshak G, Klerman G. The somatosensory amplification scale and its relationship to hypochondriasis. J Psychiatr Res. 1990;24(4):323–34. doi:10.1016/0022-3956(90)90004-A.
Jack D. Silencing the self: women and depression. New York: Harper Perennial; 1991.
Westin V, Hayes S, Andersson G. Is it the sound or your relationship to it? The role of acceptance in predicting tinnitus impact. Behav Res Ther. 2008;46(12):1259–65. doi:10.1016/j.brat.2008.08.008.
Cohen J. Statistical power analysis for the behavioral sciences 2nd ed. Hillsdale, NJ Erlbaum; 1988.
Faratian B, Gaspar A, O’Brien P, Johnson I, Filshie G, Prescott P. Premenstrual syndrome: weight, abdominal swelling, and perceived body image. Am J Obstet Gynecol. 1984;150(2):200–4. doi:10.1016/S0002-9378(84)80016-2.
Sundstrom Poromaa I, Segebladh B. Adverse mood symptoms with oral contraceptives. Acta Obstet Gynecol Scand. 2012;91(4):420–7. doi:10.1111/j.1600-0412.2011.01333.x.
Acknowledgments
We give special thanks to Alexander Alasjö for setting up the online questionnaire system, and Carolin Schilder, Jasmin Kämmerer, as well as Christine Ertz for supporting us with recruiting participants.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Maria Kleinstäuber, Katarina Schmelzer, Beate Ditzen, Gerhard Andersson, Wolfgang Hiller, and Cornelia Weise declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Kleinstäuber, M., Schmelzer, K., Ditzen, B. et al. Psychosocial Profile of Women with Premenstrual Syndrome and Healthy Controls: A Comparative Study. Int.J. Behav. Med. 23, 752–763 (2016). https://doi.org/10.1007/s12529-016-9564-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12529-016-9564-9